Lexeo Therapeutics
Develops genetic medicines for inherited cardiovascular disease and select CNS disorders.
$4.77
After-hours close−0.10 (−1.95%)
At close$4.87(−2.51%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.30 | −$0.30 | 0.0% |
| Aug 2026 | −$0.29 | −$0.30 | −5.2% |
| May 2026 | −$0.29 | −$0.25 | +13.8% |
| Mar 2026 | −$0.32 | −$0.27 | +15.6% |
The latest year is open to everyone — the 15 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | −$0.30 | −$0.30 | 0.0% | — | — | — |
| Aug 12, 2026 | −$0.29 | −$0.30 | −5.2% | — | — | — |
| May 11, 2026 | −$0.29 | −$0.25 | +13.8% | — | — | — |
| Mar 30, 2026 | −$0.32 | −$0.27 | +15.6% | — | — | — |
The latest year is open to everyone — the 15 quarters behind it read with an account. Sign in | ||||||
| Nov 5, 2025 | ||||||
| Aug 14, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 24, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 12, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 11, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Jun 30, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Dec 31, 2022 | ||||||
| Sep 30, 2022 | ||||||
| Jun 30, 2022 | ||||||
| Mar 30, 2022 | ||||||